The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age
Open accessAbstract
Abstract The utility of X-inactivation based clonality assays for evaluation of human neoplasia is well-documented. However, excessive Lyonization is a potential limitation of these assays, because it mimics clonal derivation of cells. The incidence of excessive Lyonization in healthy females is controversial, with reported incidence varying from 4% to 33%. Several explanations have been offered for the observed variation, including different criteria for excessive Lyonization, diversity of X- linked clonality assays, small population sizes and more recently, tissue specificity of X-inactivation patterns. However, it is also possible that stem cell depletion, clonal hematopoiesis, or selection pressures on blood cells results in an increased incidence of excessive skewing. If any of the latter is true, then the incidence of excessive skewing should increase with age in blood cells. To test this hypothesis, we determined X-inactivation ratios at the human androgen receptor locus of 295 normal females from three age groups: (1) neonates, (2) females 28 to 32 years old and, (3) females aged > or = 60 years. The incidence of skewing (allele ratios > or = 3:1) was 8.6% (14 of 162) in neonates (P = .104 v 28 to 32); 16.4% (11/67) in 28 to 32 y.o. (P = .0064 v > or = 60), and 37.9% (25 of 66) in women > or = 60 y.o. (P < .0001 v neonates). When a more stringent criterion for skewing was used (allele ratios > or = 10:1), the incidence was 1.9% (3 of 162) in neonates (P = .362 v 28 to 32), 4.5% (3 of 67) in 28 to 32 y.o. (P = .0022 v > or = 60), and 22.7% (15 of 66) in > or = 60 y.o. group (P < .0001 v neonates). Results have been confirmed at the phosphoglycerate kinase locus for 48 heterozygous females. The incidence of excessive skewing increases with age. In neonates, the incidence is low and may correspond to true excessive Lyonization. Acquired skewing occurs with aging in normal females and is present in 38% of females over the age of 60. Further studies are needed to determine whether acquired skewing is a consequence of stem cell depletion, true clonal hematopoiesis, growth advantage conferred by parental-specific X-chromosomes, or other causes. These data provide an explanation for variation in reported incidence of excessive skewing in normal females. Furthermore, these findings suggest that any study of clonality using X-inactivation based assays should incorporate age- matched controls for Lyonization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“during aging, blood cells are derived from fewer and fewer stem cells.”
From Aging of hematopoietic stem cells (2018) · cites this paper as [79]
In the citing paper
“However, in some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
In the citing paper
“As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP) (Busque et al., 1996; Champion et al., 1997; Vas et al., 2012).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Clonal origin of chronic myelocytic leukemia in man.
Fialkow, P., Gartler, S. M., & Yoshida, A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1468 · Cited by 532
Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H. F., Michelson, A. M., Riggs, A. D., & Orkin, S. H. (1987) · PubMed · Cited by 417
Catalog Of Mutant Genes And Polymorphic Loci
Doolitile, D. P., Davisson, M. T., Guidi, J. N., & Green, M. C. (1996) · doi:10.1093/oso/9780198548690.003.0002 · Cited by 400
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., Vaidya, K., & Murphy, S. (1981) · Blood · doi:10.1182/blood.v58.5.916.916 · Cited by 384
Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human Tumors
Vogelstein, B., Fearon, E. R., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2982210 · Cited by 379
Kay, G. F., Penny, G. D., Patel, D., Ashworth, A., Brockdorff, N., & Rastan, S. (1993) · Cell · doi:10.1016/0092-8674(93)90658-d · Cited by 364
“Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-Up
Kyle, R. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60015-9 · Cited by 344
Research works printed but not linked: 1
- Busque L, Gilliland DG: The PGK-PCR based clonality assay (PPCA), in Harwood AJ (ed): Methods in Molecular Biology: Proto- cols for Gene Analysis, vol 31. Totowa, NJ, Humana Press 1994, p 237
Cited by
Sorted by citations
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Coombs, C. C., Zehir, A., Devlin, S. M., Kishtagari, A., Syed, A., Jonsson, P., Hyman, D. M., Solit, D. B., Robson, M. E., Baselga, J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.010 · Cited by 866
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Busque, L., Patel, J. P., Figueroa, M. E., Vasanthakumar, A., Provost, S., Hamilou, Z., Mollica, L., Li, J., Viale, A., Heguy, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2413 · Cited by 830
Self-citationClonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Zink, F., Stacey, S. N., Norddahl, G. L., Frigge, M. L., Magnusson, O. T., Jonsdottir, I., Thorgeirsson, T. E., Sigurdsson, A., Gudjonsson, S. A., Gudmundsson, J., et al. (2017) · Blood · doi:10.1182/blood-2017-02-769869 · Cited by 777
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
Young, A. L., Challen, G. A., Birmann, B. M., & Druley, T. E. (2016) · Nature Communications · doi:10.1038/ncomms12484 · Cited by 692
Polycythemia vera: myths, mechanisms, and management
Spivak, J. L. (2002) · Blood · doi:10.1182/blood-2001-12-0349 · Cited by 458
Advances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 461
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Bowman, R. L., Busque, L., & Levine, R. L. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.011 · Cited by 448
Self-citationAn integrated epigenetic and genetic approach to common human disease
BJORNSSON, H. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.009 · Cited by 448
Aging of hematopoietic stem cells
de Haan, G., & Lazare, S. S. (2018) · Blood · doi:10.1182/blood-2017-06-746412 · Cited by 432
Age- and tissue-specific variation of X chromosome inactivation ratios in normal women
Sharp, A. J., Robinson, D., & Jacobs, P. A. (2000) · Human Genetics · doi:10.1007/s004390000382 · Cited by 405
The X chromosome and sex-specific effects in infectious disease susceptibility
Schurz, H., Salie, M., Tromp, G., Hoal, E. G., Kinnear, C. J., & Möller, M. (2019) · Human Genomics · doi:10.1186/s40246-018-0185-z · Cited by 419
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386
Buscarlet, M., Provost, S., Zada, Y. F., Barhdadi, A., Bourgoin, V., Lépine, G., Mollica, L., Szuber, N., Dubé, M.-P., & Busque, L. (2017) · Blood · doi:10.1182/blood-2017-04-777029 · Cited by 383
Self-citationSex differences in telomeres and lifespan
Barrett, E. L. B., & Richardson, D. S. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00741.x · Cited by 366
X Chromosome–Inactivation Patterns of 1,005 Phenotypically Unaffected Females
Amos-Landgraf, J. M., Cottle, A. A., Plenge, R. M., Friez, M., Schwartz, C. E., Longshore, J. W., & Willard, H. F. (2006) · The American Journal of Human Genetics · doi:10.1086/507565 · Cited by 343
Blok, L. S., Madsen, E. C., Juusola, J., Gilissen, C., Baralle, D., Reijnders, M. R. F., Venselaar, H., Helsmoortel, C., Cho, M. T., Hoischen, A., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.004 · Cited by 301
Somatic mosaicism: implications for disease and transmission genetics
Campbell, I. M., Shaw, C. A., Stankiewicz, P., & Lupski, J. R. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.013 · Cited by 296
Age-related clonal hematopoiesis
Shlush, L. I. (2018) · Blood · doi:10.1182/blood-2017-07-746453 · Cited by 281
Královics, R., Teo, S.-S., Li, S., Theocharides, A. P. A., Buser, A. S., Tichelli, A., & Skoda, R. C. (2006) · Blood · doi:10.1182/blood-2005-11-009605 · Cited by 275
Rich-Edwards, J. W., Kaiser, U. B., Chen, G. L., Manson, J. E., & Goldstein, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00246 · Cited by 273
Clonal expansion in non-cancer tissues
Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Perner, F., Perner, C., Ernst, T., & Heidel, F. H. (2019) · Cells · doi:10.3390/cells8080854 · Cited by 248
Levine, R. L., Bélisle, C., Wadleigh, M., Zahrieh, D., Lee, S. J., Chagnon, P., Gilliland, D. G., & Busque, L. (2006) · Blood · doi:10.1182/blood-2005-09-3900 · Cited by 239
Self-citationGermeshausen, M., Ballmaier, M., & Welte, K. (2006) · Blood · doi:10.1182/blood-2006-02-004275 · Cited by 229
Concepts of human leukemic development
Warner, J. K., Wang, J. C. Y., Hope, K. J., Jin, L., & Dick, J. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207933 · Cited by 226
Harrison, C. N., Gale, R. E., Machin, S. J., & Linch, D. C. (1999) · Blood · doi:10.1182/blood.v93.2.417 · Cited by 214
Hickey, T. E., Chandy, A., & Norman, R. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8137 · Cited by 204
Clonal hematopoiesis in acquired aplastic anemia
Ogawa, S. (2016) · Blood · doi:10.1182/blood-2016-01-636381 · Cited by 205
Clinical consequences of clonal hematopoiesis of indeterminate potential
Steensma, D. P. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020222 · Cited by 194
Clinical consequences of clonal hematopoiesis of indeterminate potential
Steensma, D. P. (2018) · Hematology · doi:10.1182/asheducation-2018.1.264 · Cited by 189
Arthus, M., LONERGAN, M. G. A., CRUMLEY, M. J., Naumova, A. K., Morin, D., Marco, L. A. D., Kaplan, B. S., Robertson, G. L., Sasaki, S., MORGAN, K., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1161044 · Cited by 183
Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking
Dawoud, A. A. Z., Tapper, W., & Cross, N. C. P. (2020) · Leukemia · doi:10.1038/s41375-020-0896-8 · Cited by 180
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
Marciano, B. E., Zerbe, C. S., Falcone, E. L., Ding, L., Ravin, S. S. D., Daub, J. R., Kreuzburg, S., Yockey, L., Hunsberger, S., Foruraghi, L., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.035 · Cited by 186
Skewed X-inactivation is common in the general female population
Shvetsova, E., Sofronova, A. A., Monajemi, R., Gagalova, K., Draisma, H. H. M., White, S. J., Santen, G. W. E., Lopes, S. M. C. D. S., Heijmans, B. T., van Meurs, J. B. J., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0291-3 · Cited by 165
Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells
Akunuru, S., & Geiger, H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.003 · Cited by 178
JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Sano, S., Wang, Y., Yura, Y., Sano, M., Oshima, K., Yang, Y., Katanasaka, Y., Min, K.-D., Matsuura, S., Ravid, K., et al. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.013 · Cited by 170
Futatani, T., Miyawaki, T., Tsukada, S., Hashimoto, S., Kunikata, T., Arai, S., Kurimoto, M., Niida, Y., Matsuoka, H., Sakiyama, Y., et al. (1998) · PubMed · Cited by 168
Unraveling Hematopoiesis through the Lens of Genomics
Liggett, L. A., & Sankaran, V. G. (2020) · Cell · doi:10.1016/j.cell.2020.08.030 · Cited by 163
Cardiovascular Disease, Aging, and Clonal Hematopoiesis
Evans, M. A., Sano, S., & Walsh, K. X. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032544 · Cited by 169
Somatic Mutations and Clonal Hematopoiesis
Fuster, J. J., & Walsh, K. X. (2018) · Circulation Research · doi:10.1161/circresaha.117.312115 · Cited by 166
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161
Fusco, F. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh192 · Cited by 155
The dynamics of X‐inactivation skewing as women age
Hatakeyama, C., Anderson, C., Beever, C. L., Peñaherrera, M., Brown, C. J., & Robinson, W. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00310.x · Cited by 150
Buscarlet, M., Provost, S., Zada, Y. F., Bourgoin, V., Mollica, L., Dubé, M.-P., & Busque, L. (2018) · Blood · doi:10.1182/blood-2018-01-829937 · Cited by 146
Self-citationKarim (2015) · doi:10.1210/jc.2014-2834 · Cited by 142
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01411-9 · Cited by 143
The causes and consequences of random and non‐random X chromosome inactivation in humans
Brown, C. J., & Robinson, W. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580504.x · Cited by 136
X chromosome inactivation in clinical practice
Ørstavik, K. H. (2009) · Human Genetics · doi:10.1007/s00439-009-0670-5 · Cited by 130
Commitment to X Inactivation Precedes the Twinning Event in Monochorionic MZ Twins
Monteiro, J., Derom, C. A., VLIETINCK, R. F., Kohn, N. E., LESSER, M. L., & Gregersen, P. K. (1998) · The American Journal of Human Genetics · doi:10.1086/301978 · Cited by 129
Myelodysplastic syndrome is not merely “preleukemia”
Albitar, M. X., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H. M., Rogers, A. M., Jilani, I. B., Lin, C., Pierce, S. A., et al. (2002) · Blood · doi:10.1182/blood.v100.3.791 · Cited by 129
Froissart, R. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00136-7 · Cited by 128
Ferrando, A. A., & López-Otín, C. (2017) · Nature Medicine · doi:10.1038/nm.4410 · Cited by 132
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
Spivak, J. L. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.02.011 · Cited by 127
Age-associated changes in human hematopoietic stem cells
Pang, W. W., Schrier, S. L., & Weissman, I. L. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.004 · Cited by 126
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
de Médecine, F., Curie, M., Générale, M., & Pelizzari, M. (2011) · Cited by 123
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 124
X-linked genetic factors regulate hematopoietic stem-cell kinetics in females
Christensen, K., Kristiansen, M. B., Hagen-Larsen, H., Skytthe, A., Bathum, L., Jeune, B., Andersen‐Ranberg, K., Vaupel, J. W., & Ørstavik, K. H. (2000) · Blood · doi:10.1182/blood.v95.7.2449 · Cited by 121
Bottomley, S. S., & Fleming, M. D. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.008 · Cited by 120
Lau, A., Brown, C. J., Peñaherrera, M. S., Langlois, S., Kalousek, D. K., & Robinson, W. P. (1997) · The American Journal of Human Genetics · doi:10.1086/301651 · Cited by 120
No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans
Bolduc, V., Chagnon, P., Provost, S., Dubé, M., Bélisle, C., Gingras, M., Mollica, L. R., & Busque, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33166 · Cited by 114
Self-citationJan, M., Ebert, B. L., & Jaiswal, S. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.002 · Cited by 119
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
Babushok, D. V., Perdigones, N., Perin, J. C., Olson, T. S., Ye, W., Roth, J. J., Lind, C., Cattier, C., Li, Y., Hartung, H. D., et al. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.01.007 · Cited by 118
Genetic and epigenetic determinants of AML pathogenesis
Cai, S. F., & Levine, R. L. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.08.001 · Cited by 117
Effects ofMECP2mutation type, location and X‐inactivation in modulating Rett syndrome phenotype
Weaving, L. S., Williamson, S. L., Bennetts, B., Davis, M. R., Ellaway, C., Leonard, H., Thong, M., Delatycki, M. B., Thompson, E. M., Laing, N. G., et al. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10053 · Cited by 121
Twin study of genetic and aging effects on X chromosome inactivation
Kristiansen, M. B., Knudsen, G. P., Bathum, L., Naumova, A. K., Sørensen, T. I. A., Brix, T. H., Svendsen, A. J., Christensen, K., Kyvik, K. O., & Ørstavik, K. H. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201398 · Cited by 107
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116
Beel, K. A., Cotter, M. M., Blatný, J., Bond, J., Lucas, G., Green, F., Vanduppen, V., Leung, D. W., Rooney, S., Smith, O. P., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07416.x · Cited by 110
Association of Androgen Receptor CAG Repeat Polymorphism and Polycystic Ovary Syndrome
Shah, N. A., Antoine, H. J., Pall, M., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0038 · Cited by 108
Fieremans, N., Esch, H. V., Holvoet, M., Goethem, G. V., Devriendt, K., Rosello, M., Mayo, S., Martı́nez, F., Jhangiani, S. N., Muzny, D. M., et al. (2016) · Human Mutation · doi:10.1002/humu.23012 · Cited by 108
Clonal hematopoiesis, somatic mosaicism, and age-associated disease
Evans, M. A., & Walsh, K. X. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2022 · Cited by 112
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors
Reed, S. C., Croessmann, S., & Park, B. H. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2598 · Cited by 112
Discovering the drivers of clonal hematopoiesis
Pich, O., Reyes-Salazar, I., González-Pérez, A., & López-Bigas, N. (2022) · Nature Communications · doi:10.1038/s41467-022-31878-0 · Cited by 100
Wolach, B., Scharf, Y., Gavrieli, R., de Boer, M., & Roos, D. (2004) · Blood · doi:10.1182/blood-2004-02-0675 · Cited by 96
New Insights from Studies of Clonal Hematopoiesis
Gibson, C. J., & Steensma, D. P. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3044 · Cited by 97
Kanegane, H., Futatani, T., Wang, Y., Nomura, K. T., Shinozaki, K., Matsukura, H., Kubota, T., Tsukada, S., & Miyawaki, T. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.120133 · Cited by 95
Cazzola, M., May, A. M., Bergamaschi, G., Cerani, P., Rosti, V., & Bishop, D. F. (2000) · Blood · doi:10.1182/blood.v96.13.4363 · Cited by 94
Severe and moderate haemophilia A and B in US females
Michele, D. M. D., Gibb, C. B., Lefkowitz, J. M., Ni, Q., Gerber, L. M., & Ganguly, A. A. (2014) · Haemophilia · doi:10.1111/hae.12364 · Cited by 93
Premature Aging in Young Cancer Survivors
Armenian, S. H., Gibson, C. J., Rockne, R. C., & Ness, K. K. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy229 · Cited by 95
Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay
Kuijper, A., Buerger, H., Simon, R., Schaefer, K., Croonen, A., Boecker, W., van der Wall, E., & van Diest, P. J. (2002) · The Journal of Pathology · doi:10.1002/path.1161 · Cited by 93
Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
Camaschella, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.07.001 · Cited by 92
Rösen‐Wolff, A., Soldan, W., Heyne, K., Bickhardt, J., Gahr, M. L., & Roesler, J. (2001) · Annals of Hematology · doi:10.1007/s002770000230 · Cited by 90
An X chromosome gene regulates hematopoietic stem cell kinetics
Abkowitz, J. L., Taboada, M. R., Shelton, G. H., Catlin, S. N., Guttorp, P. M., & Kiklevich, J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3862 · Cited by 90
Viggiano, E., Ergoli, M., Picillo, E., & Politano, L. (2016) · Human Genetics · doi:10.1007/s00439-016-1666-6 · Cited by 88
Najfeld, V., Montella, L., Scalise, A., & Fruchtman, S. M. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03763.x · Cited by 89
Vottero, A., Stratakis, C. A., Ghizzoni, L., Longui, C., Karl, M., & Chrousos, G. (1999) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.84.3.5540 · Cited by 95
Managing Clonal Hematopoiesis in Patients With Solid Tumors
Bolton, K. L., Gillis, N., Coombs, C. C., Takahashi, K., Zehir, A., Bejar, R. L., Garcia‐Manero, G., Futreal, P. A., Jensen, B. C., Diaz, L. A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00331 · Cited by 87
Busque, L., Sun, M., Buscarlet, M., Ayachi, S., Feroz Zada, Y., Provost, S., Bourgoin, V., Mollica, L., Meisel, M., Hinterleitner, R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000770 · Cited by 87
Self-citationUnbalanced X‐chromosome inactivation in haemopoietic cells from normal women
Tonon, L., Bergamaschi, G., Dellavecchia, C., Rosti, V., Lucotti, C., Malabarba, L., Novella, A., Vercesi, E., Frassoni, F., & Cazzola, M. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00867.x · Cited by 86
Busque, L., Paquette, Y., Provost, S., Roy, D., Levine, R. L., Mollica, L. R., & Gilliland, D. G. (2009) · Blood · doi:10.1182/blood-2008-12-195677 · Cited by 85
Self-citationHigh frequency of skewed X inactivation in young breast cancer patients
Kristiansen, M. B., Langerød, A., Knudsen, G. P., Weber, B. L., Børresen-Dale, A.-L., & Ørstavik, K. H. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.30 · Cited by 86
Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
Reeder, T. L., Bailey, R. J., Dewald, G. W., & Tefferi, A. (2003) · Blood · doi:10.1182/blood-2002-07-2341 · Cited by 86
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD
Khetarpal, S. A., Qamar, A., Bick, A. G., Fuster, J. J., Kathiresan, S., Jaiswal, S., & Natarajan, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.045 · Cited by 88
Futatani, T., Watanabe, C., Baba, Y., Tsukada, S., & Ochs, H. D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02905.x · Cited by 84
The structural basis of g-protein-coupled receptor function and dysfunction in human diseases
Schöneberg, T., Schulz, A. M., & Gudermann, T. W. (2007) · Springer eBooks · doi:10.1007/bfb0116587 · Cited by 84
X-Chromosome Inactivation and Related Diseases
Sun, Z., Fan, J., & Wang, Y. (2022) · Genetics Research · doi:10.1155/2022/1391807 · Cited by 93
Non-random X chromosome inactivation in mammalian cells
Migeon, B. R. (1998) · Cytogenetic and Genome Research · doi:10.1159/000014971 · Cited by 83
Germline risk of clonal haematopoiesis
Silver, A. J., Bick, A. G., & Savona, M. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00356-6 · Cited by 86
Metadata
- Authors
- Busque, L., Mio, R., Mattioli, J., Brais, E., Blais, N., Lalonde, Y., Maragh, M., & Gilliland, D.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Research Center, Hopital Maisonneuve-Rosemont, University of Montreal, Quebec, Canada.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-07-01
- Volume
- 88
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W4242239767
- Cited by
- 543
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 29 · 2020: 24 · 2019: 29 · 2018: 30 · 2017: 22 · 2016: 17 · 2015: 12 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA47261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- X chromosome inactivation, X-inactivation skewing, heterozygous females, stem cell depletion, clonal hematopoiesis, neonates, healthy women, blood cells, X-inactivation patterns
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Clone Cells, Dosage Compensation, Genetic, Female, Heterozygote, Humans, Infant, Newborn, Methylation, Middle Aged, Models, Biological, Molecular Sequence Data, Phosphoglycerate Kinase, Transcription Factors, Polymerase Chain Reaction, Artifacts, Cell Lineage, RNA, Untranslated, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review